University of Tasmania
Browse

Inhibiting bone morphogenetic protein 4 Type I receptor signaling promotes remyelination by potentiating oligodendrocyte differentiation

Download (6.94 MB)
journal contribution
posted on 2023-05-21, 03:18 authored by Govier-Cole, AE, Wood, RJ, Jessica FletcherJessica Fletcher, Gonsalvez, DG, Merlo, D, Cate, HS, Murray, SS, Xiao, J
Blocking inhibitory factors within CNS demyelinating lesions is regarded as a promising strategy to promote remyelination. Bone morphogenetic protein 4 (BMP4) is an inhibitory factor present in demyelinating lesions. Noggin, an endogenous antagonist to BMP, has previously been shown to increase the number of oligodendrocytes and promote remyelination in vivo. However, it remains unclear how BMP4 signaling inhibits remyelination. Here we investigated the downstream signaling pathway that mediates the inhibitory effect that BMP4 exerts upon remyelination through pharmacological and transgenic approaches. Using the cuprizone mouse model of central demyelination, we demonstrate that selectively blocking BMP4 signaling via the pharmacological inhibitor LDN-193189 significantly promotes oligodendroglial differentiation and the extent of remyelination in vivo This was accompanied by the downregulation of transcriptional targets that suppress oligodendrocyte differentiation. Further, selective deletion of BMP receptor type IA (BMPRIA) within primary mouse oligodendrocyte progenitor cells (OPCs) significantly enhanced their differentiation and subsequent myelination in vitro Together, the results of this study identify that BMP4 signals via BMPRIA within OPCs to inhibit oligodendroglial differentiation and their capacity to myelinate axons, and suggest that blocking the BMP4/BMPRIA pathway in OPCs is a promising strategy to promote CNS remyelination.

History

Publication title

eNeuro

Volume

6

Pagination

1-22

ISSN

2373-2822

Department/School

Menzies Institute for Medical Research

Publisher

Society for Neuroscience

Place of publication

United States

Rights statement

Copyright © 2019 Govier-Cole et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

Repository Status

  • Open

Socio-economic Objectives

Expanding knowledge in the biomedical and clinical sciences

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC